Regulation of ovarian angiogenesis and apoptosis by GnRH-I analogs

Molecular Reproduction and Development

Volumn 75, Issue 4, 2008, Pages 623-631

  Parborell, Fernanda ^a   Irusta, Griselda ^a   Celín, Alejandra Rodríguez ^a   Tesone, Marta ^a,b  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Angiogenesis; Apoptosis; GnRH I analogs; Ovary

Indexed keywords

ANGIOPOIETIN RECEPTOR; CASPASE 3; ITURELIX; LEUPRORELIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; IMMUNOCHEMISTRY; IN VIVO STUDY; NONHUMAN; OVARY; OVARY FOLLICLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANGIOPOIETIN-1; ANIMALS; APOPTOSIS; CASPASE 3; ENZYME ACTIVATION; FEMALE; GONADOTROPIN-RELEASING HORMONE; INJECTIONS, SUBCUTANEOUS; LEUPROLIDE; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGOPEPTIDES; OVARIAN FOLLICLE; OVARY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, TIE-2; STRUCTURE-ACTIVITY RELATIONSHIP; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

RATTUS;

EID: 40049085911     PISSN: 1040452X     EISSN: 10982795     Source Type: Journal    
DOI: 10.1002/mrd.20806     Document Type: Article

References (63)

1. Abramovich D, Parborell F, Tesone M. 2006. Effect of a vascular endothelial growth factor (VEGF) inhibitory treatment on the folliculogenesis and ovarian apoptosis in gonadotropin-treated prepubertal rats. Biol Reprod 75:434-441.
2. Andreu C, Parborell F, Vanzulli S, Chemes H, Tesone M. 1998. Regulation of follicular luteinization by a gonadotropin-releasing hormone agonist: Relationship between steroidogenesis and apoptosis. Mol Reprod Dev 51:287-294.
3. Aten RF, Williams AT, Behrman HR. 1986. Ovarian gonadotropin-releasing hormone-like protein(s): Demonstration and characterization. Endocrinology 118:961-967.
4. Aten RF, Polan ML, Bayless R, Behrman HR. 1987. A gonadotropin-releasing hormone (GnRH)-like protein in human ovaries: Similarity to the GnRH-like ovarian protein of the rat. J Clin Endocrinol Metab 64:1288-1293.
5. Barboni B, Turriani M, Galeati G, Spinaci M, Bacci ML, Forni M, Mattioli M. 2000. Vascular endothelial growth factor production in growing pig antral follicles. Biol Reprod 63:858-864.
6. Birnbaumer L, Shahabi N, Rivier J, Vale W. 1985. Evidence for a physiological role of gonadotropin-releasing hormone (GnRH) or GnRH-like material in the ovary. Endocrinology 116:1367-1370.
7. Boone DL, Tsang BK. 1998. Caspase-3 in the rat ovary: Localization and possible role in follicular atresia and luteal regression. Biol Reprod 58:1533-1539.
8. Celik-Ozenci C, Akkoyunlu G, Kayisli UA, Arici A, Demir R. 2003. Localization of vascular endothelial growth factor in the zona pellucida of developing ovarian follicles in the rat: A possible role in destiny of follicles. Histochem Cell Biol 120:383-390.
9. Cheng CK, Leung PC. 2005. Molecular biology of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and their receptors in humans. Endocr Rev 26:283-306.
10. Clayton RN, Eccleston L, Gossard F, Thalbard JC, Morel G. 1992. Rat granulosa cells express the gonadotrophin-releasing hormone gene: Evidence from in-situ hybridization histochemistry. J Mol Endocrinol 9:189-195.
11. Danial NN, Korsmeyer SJ. 2004. Cell death: Critical control points. Cell 116:205-219.
12. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. 1992. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991.
13. Fan TJ, Han LH, Cong RS, Liang J. 2005. Caspase family proteases and apoptosis. Acta Biochim Biophys Sin (Shanghai) 37:719-727.
14. Ferrara N. 2002. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: Therapeutic implications. Semin Oncol 29:10-14.
15. Flaws JA, Kugu K, Trbovich AM, DeSanti A, Tilly KI, Hirshfield AN, Tilly JL. 1995. Interleukin-1 beta-converting enzyme-related proteases (IRPs) and mammalian cell death: Dissociation of IRP-induced oligonucleosomal endonuclease activity from morphological apoptosis in granulosa cells of the ovarian follicle. Endocrinology 136:5042-5053.
16. Fraser HM. 2006. Regulation of the ovarian follicular vasculature. Reprod Biol Endocrinol 4:18.
17. Fraser HM, Bramley TA, Miller WR, Sharpe RM. 1986. Extra pituitary actions of LHRH analogues in tissues of the human female and investigation of the existence and function of LHRH-like peptides. Prog Clin Biol Res 225:29-54.
18. Goubau S, Bond CT, Adelman JP, Misra V, Hynes MF, Schultz GA, Murphy BD. 1992. Partial characterization of the gonadotropin-releasing hormone (GnRH) gene transcript in the rat ovary. Endocrinology 130:3098-3100.
19. Green DR. 1998. Apoptotic pathways: The roads to ruin. Cell 94:695-698.
20. Greenaway J, Connor K, Pedersen HG, Coomber BL, LaMarre J, Petrik J. 2004. Vascular endothelial growth factor and its receptor, Flk-1/ KDR, are cytoprotective in the extravascular compartment of the ovarian follicle. Endocrinology 145:2896-2905.
21. Guerrero HE, Stein P, Asch RH, de Fried EP, Tesonen M. 1993. Effect of a gonadotropin-releasing hormone agonist on luteinizing hormone receptors and steroidogenesis in ovarian cells. Fertil Steril 59:803-808.
22. Hazum E, Nimrod A. 1982. Photoaffinity-labeling and fluorescence- distribution studies of gonadotropin-releasing hormone receptors in ovarian granulosa cells. Proc Natl Acad Sci U S A 79:1747-1750.
23. Hazzard TM, Christenson LK, Stouffer RL. 2000. Changes in expression of vascular endothelial growth factor and angiopoietin-1 and -2 in the macaque corpus luteum during the menstrual cycle. Mol Hum Reprod 6:993-998.
24. Hsueh AJ, Erickson GF. 1979. Extrapituitary action of gonadotropin-releasing hormone: Direct inhibition ovarian steroidogenesis. Science 204:854-855.
25. Hsueh AJ, Schaeffer JM. 1985. Gonadotropin-releasing hormone as a paracrine hormone and neurotransmitter in extra-pituitary sites. J Steroid Biochem 23:757-764.
26. Kaiser UB, Zhao D, Cardona GR, Chin WW. 1992. Isolation and characterization of cDNAs encoding the rat pituitary gonadotropin-releasing hormone receptor. Biochem Biophys Res Commun 189:1645-1652.
27. Kang SK, Choi KC, Cheng KW, Nathwani PS, Auersperg N, Leung PC. 2000. Role of gonadotropin-releasing hormone as an autocrine growth factor in human ovarian surface epithelium. Endocrinology 141:72-80.
28. Kang SK, Tai CJ, Nathwani PS, Leung PC. 2001. Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid in human granulosa-luteal cells. Endocrinology 142:182-192.
29. Kayalar C, Ord T, Testa MP, Zhong LT, Bredesen DE. 1996. Cleavage of actin by interleukin 1 beta-converting enzyme to reverse DNase I inhibition. Proc Natl Acad Sci U S A 93:2234-2238.
30. Kim SH, Yoo CI, Kim HT, Park JY, Kwon CH, Kim YK. 2006. Activation of peroxisome proliferator-activated receptor-gamma (PPARgamma) induces cell death through MAPK-dependent mechanism in osteoblastic cells. Toxicol Appl Pharmacol 215:198-207.
31. Kitajima Y, Endo T, Manase K, Nishikawa A, Shibuya M, Kudo R. 2004. Gonadotropin-releasing hormone agonist administration reduced vascular endothelial growth factor (VEGF), VEGF receptors, and vascular permeability of the ovaries of hyperstimulated rats. Fertil Steril 81:842-849.
32. Kitajima Y, Endo T, Nagasawa K, Manase K, Honnma H, Baba T, Hayashi T, Chiba H, Sawada N, Saito H. 2006. Hyperstimulation and a gonadotropin-releasing hormone agonist modulate ovarian vascular permeability by altering expression of the tight junction protein claudin-5. Endocrinology 147:694-699.
33. Knecht M, Ranta T, Feng P, Shinohara O, Catt KJ. 1985. Gonadotropin-releasing hormone as a modulator of ovarian function. J Steroid Biochem Mol Biol 23:771-778.
34. Lavrik IN, Golks A, Krammer PH. 2005. Caspases: Pharmacological manipulation of cell death. J Clin Invest 115:2665-2672.
35. Mattot V, Moons L, Lupu F, Chernavvsky D, Gomez RA, Collen D, Carmeliet P. 2002. Loss of the VEGF(164) and VEGF(188) isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice. J Am Soc Nephrol 13:1548-1560.
36. Muttukrishna S, Fowler PA, George L, Groome NP, Knight PG. 1996. Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy. J Clin Endocrinol Metab 81:3328-3334.
37. Nelipovich PA, Nikonova LV, Umansky SR. 1988. Inhibition of poly(ADP-ribose) polymerase as a possible reason for activation of Ca2+/Mg2+-dependent endonuclease in thymocytes of irradiated rats. Int J Radiat Biol Relat Stud Phys Chem Med 53:749-765.
38. Nicholson DW. 1999. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 6:1028-1042.
39. Oikawa M, Dargan C, Ny T, Hsueh AJ. 1990. Expression of gonadotropin-releasing hormone and prothymosin-alpha messenger ribonucleic acid in the ovary. Endocrinology 127:2350-2356.
40. Orly J, Rei Z, Greenberg NM, Richards JS. 1994. Tyrosine kinase inhibitor AG18 arrests follicle-stimulating hormone- induced granulosa cell differentiation: Use of reverse transcriptase- polymerase chain reaction assay for multiple messenger ribonucleic acids. Endocrinology 134:2336-2346.
41. Pajusola K, Aprelikova O, Korhonen J, Kaipainen A, Pertovaara L, Alitalo R, Alitalo K. 1992. FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res 52:5738-5743.
42. Parborell F, Dain L, Tesone M. 2001. Gonadotropin-releasing hormone agonist affects rat ovarian follicle development by interfering with FSH and growth factors on the prevention of apoptosis. Mol Reprod Dev 60:241-247.
43. Parborell F, Pecci A, Gonzalez O, Vitale A, Tesone M. 2002. Effects of a gonadotropin-releasing hormone agonist on rat ovarian follicle apoptosis: Regulation by EGF and the expression of Bcl-2-related genes. Biol Reprod 67:481-486.
44. Parborell F, Irusta G, Vitale AM, Gonzalez O, Pecci A, Tesone M. 2005. GnRH antagonist Antide inhibits apoptosis of preovulatory follicle cells in rat ovary. Biol Reprod 72:659-666.
45. Peng C, Fan N, Ligier M, Vaananen J, Leung PC. 1994. Expression and regulation of gonadotropin-releasing hormone (GnRH) receptor messenger ribonucleic acids in human granulosa-luteal cells. Endocrinology 135:1740-1746.
46. Piquette GN, Lapolt PS, Oikawa M, Hsueh AJ. 1991. Regulation of luteinizing hormone receptor messenger ribonucleic acid levels by gonadotropins, growth factors, and gonadotropin-releasing hormone in cultured rat granulosa cells. Endocrinology 128:2449-2456.
47. Rosen A, Casciola-Rosen L. 1997. Macromolecular substrates for the ICE-like proteases during apoptosis. J Cell Biochem 64:50-54.
48. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC. 1995. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66.
49. Shi Y. 2004. Caspase activation, inhibition, and reactivation: A mechanistic view. Protein Sci 13:1979-1987.
50. Sridaran R, Lee MA, Haynes L, Srivastava RK, Ghose M, Sridaran G, Smith CJ. 1999a. GnRH action on luteal steroidogenesis during pregnancy. Steroids 64:618-623.
51. Sridaran R, Philip GH, Li H, Culty M, Liu Z, Stocco DM, Papadopoulos V. 1999b. GnRH agonist treatment decreases progesterone synthesis, luteal peripheral benzodiazepine receptor mRNA, ligand binding and steroidogenic acute regulatory protein expression during pregnancy. J Mol Endocrinol 22:45-54.
52. Stouffer RL, Martinez-Chequer JC, Molskness TA, Xu F, Hazzard TM. 2001. Regulation and action of angiogenic factors in the primate ovary. Arch Med Res 32:567-575.
53. Suzuki N, Takahashi S, Okabe S. 1998. Relationship between vascular endothelial growth factor and angiogenesis in spontaneous and indomethacin-delayed healing of acetic acid-induced gastric ulcers in rats. J Physiol Pharmacol 49:515-527.
54. Tilly JL, Billig H, Kowalski KI, Hsueh AJ. 1992a. Epidermal growth factor and basic fibroblast growth factor suppress the spontaneous onset of apoptosis in cultured rat ovarian granulosa cells and follicles by a tyrosine kinase-dependent mechanism. Mol Endocrinol 6:1942-1950.
55. Tilly JL, Kowalski KI, Schomberg DW, Hsueh AJ. 1992b. Apoptosis in atretic ovarian follicles is associated with selective decreases in messenger ribonucleic acid transcripts for gonadotropin receptors and cytochrome P450 aromatase. Endocrinology 131:1670-1676.
56. Tilly JL, Tilly KI, Kenton ML, Johnson AL. 1995. Expression of members of the bcl-2 gene family in the immature rat ovary: Equine chorionic gonadotropin-mediated inhibition of granulosa cell apoptosis is associated with decreased bax and constitutive bcl-2 and bcl-xlong messenger ribonucleic acid levels. Endocrinology 136:232-241.
57. Widlak P, Li P, Wang X, Garrard WT. 2000. Cleavage preferences of the apoptotic endonuclease DFF40 (caspase-activated DNase or nuclease) on naked DNA and chromatin substrates. J Biol Chem 275:8226-8232.
58. Wulff C, Wiegand SJ, Saunders PT, Scobie GA, Fraser HM. 2001. Angiogenesis during follicular development in the primate and its inhibition by treatment with truncated Flt-1-Fc (vascular endothelial growth factor Trap(A40)). Endocrinology 142:3244-3254.
59. Yacobi K, Wojtowicz A, Tsafriri A, Gross A. 2004. Gonadotropins enhance caspase-3 and -7 activity and apoptosis in the theca-interstitial cells of rat preovulatory follicles in culture. Endocrinology 145:1943-1951.
60. Yang S, Toy K, Ingle G, Zlot C, Williams PM, Fuh G, Li B, de Vos A, Gerritsen ME. 2002. Vascular endothelial growth factor-induced genes in human umbilical vein endothelial cells: Relative roles of KDR and Flt-1 receptors. Arterioscler Thromb Vasc Biol 22:1797-1803.
61. Yang H, Bhat GK, Wadley R, Wright KL, Chung BM, Whittaker JA, Dharmarajan AM, Sridaran R. 2003. Gonadotropin-releasing hormone-agonist inhibits synthesis of nitric oxide and steroidogenesis by luteal cells in the pregnant rat. Biol Reprod 68:2222-2231.
62. Yano T, Yano N, Matsumi H, Morita Y, Tsutsumi O, Schally AV, Taketani Y. 1997. Effect of luteinizing hormone-releasing hormone analogs on the rat ovarian follicle development. Horm Res 48: 35-41.
63. Zimmermann RC, Xiao E, Husami N, Sauer MV, Lobo R, Kitajewski J, Ferin M. 2001. Short-term administration of antivascular endothelial growth factor antibody in the late follicular phase delays follicular development in the rhesus monkey. J Clin Endocrinol Metab 86:768-772.